pentetic acid has been researched along with Bronchopulmonary Dysplasia in 1 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Brodovich, H | 1 |
| Coates, G | 1 |
1 other study available for pentetic acid and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Pulmonary clearance of 99mTc-DTPA in infants who subsequently develop bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Half-Life; Humans; Hyaline Membrane Disease; Infant, Newborn; Lung; Meta | 1988 |